Oxford Science Enterprises transferred 8,797,770 Barinthus Biotherapeutics shares at $0.11 per share, leaving its reported ownership at 0 shares. The transaction represented about 100.0% of the insider’s prior holding, giving investors a clear measure of the disclosed ownership change involving Barinthus Biotherapeutics.

Key Highlights

  • Oxford Science Enterprises plc’s transaction represented about 100.0% of its prior Barinthus Biotherapeutics holding.
  • The insider’s reported ownership after the transaction was 0 shares.
  • The transaction was classified under code U and dated 9 September 2026.

Barinthus Biotherapeutics plc. saw Oxford Science Enterprises plc transact 8,797,770 shares at $0.11 per share.

Code U Transaction Priced at $0.11

The record connects the transaction with Oxford Science Enterprises plc’s reported ownership position in Barinthus Biotherapeutics. The reported post-transaction position was 0 shares.

Disclosed Ownership Position Moves to Zero

The ownership figures show a complete change in Oxford Science Enterprises plc’s reported position. The transaction accounted for about 100.0% of its prior shares holding, while the resulting disclosed balance was 0 shares in Barinthus Biotherapeutics plc.